Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
Clinical trial NCT01030952 · COMPLETED
Trial details
- NCT number
- NCT01030952
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.